Paper of the Month

Update on the pathologic diagnosis of chronic myelomonocytic Leukemia

Daniel A. Arber Attillio Orazi
This is a review of the current diagnostic criteria for chronic myelomonocytic leukaemia which now incorporates the use of molecular genetic studies, helping to inform prognosis.

Download Article

IPSS-R MDS Risk Assessment Calculator

Revised International Prognostic Scoring System (IPSS-R) for Myelodysplastic Syndromes Risk Assessment Calculator


Click here

MDS Fact Sheet

MDS Factsheet for GPs General Practicioners

MDS Fact Sheet

Click here

NICE Guideline

Lenalidomide for treating myelodysplastic syndromes (MDS) associated with an isolated deletion 5q cytogenetic abnormality.

NICE logo

Click here

BSH Guidelines

This is an external link to the home of the British Society for Haematology (BSH). 

BSH Logo Strapline RGB

Click here